Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Mallinckrodt
Teva
Harvard Business School
Julphar
Cantor Fitzgerald
McKinsey
Johnson and Johnson
McKesson

Generated: June 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020470

« Back to Dashboard

NDA 020470 describes CLARITIN-D 24 HOUR, which is a drug marketed by Bayer Healthcare Llc and is included in one NDA. It is available from two suppliers. Additional details are available on the CLARITIN-D 24 HOUR profile page.

The generic ingredient in CLARITIN-D 24 HOUR is loratadine; pseudoephedrine sulfate. There are thirty-nine drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the loratadine; pseudoephedrine sulfate profile page.
Summary for 020470
Tradename:CLARITIN-D 24 HOUR
Applicant:Bayer Healthcare Llc
Ingredient:loratadine; pseudoephedrine sulfate
Patents:0
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 020470
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CLARITIN-D 24 HOUR loratadine; pseudoephedrine sulfate TABLET, EXTENDED RELEASE;ORAL 020470 NDA Bayer HealthCare LLC. 11523-4332 N 11523-4332-1
CLARITIN-D 24 HOUR loratadine; pseudoephedrine sulfate TABLET, EXTENDED RELEASE;ORAL 020470 NDA Bayer HealthCare LLC. 11523-4332 N 11523-4332-2

Profile for product number 002

Active Rx/OTC/Discontinued:OTCDosage:TABLET, EXTENDED RELEASE;ORALStrength10MG;240MG
Approval Date:Nov 27, 2002TE:RLD:Yes

Expired US Patents for NDA 020470

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bayer Healthcare Llc CLARITIN-D 24 HOUR loratadine; pseudoephedrine sulfate TABLET, EXTENDED RELEASE;ORAL 020470-002 Nov 27, 2002 ➤ Try a Free Trial ➤ Try a Free Trial
Bayer Healthcare Llc CLARITIN-D 24 HOUR loratadine; pseudoephedrine sulfate TABLET, EXTENDED RELEASE;ORAL 020470-002 Nov 27, 2002 ➤ Try a Free Trial ➤ Try a Free Trial
Bayer Healthcare Llc CLARITIN-D 24 HOUR loratadine; pseudoephedrine sulfate TABLET, EXTENDED RELEASE;ORAL 020470-002 Nov 27, 2002 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Teva
Federal Trade Commission
Chubb
Cantor Fitzgerald
Deloitte
Express Scripts
Julphar
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.